These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7497817)

  • 21. Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia.
    Murakami K; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 2000 Oct; 46(4):629-32. PubMed ID: 11020264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremic pneumococcal pneumonia associated with macrolide failure.
    Dylewski J; Davidson R
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):39-42. PubMed ID: 16411124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
    Decousser JW; Methlouthi I; Pina P; Allouch P;
    J Antimicrob Chemother; 2005 Mar; 55(3):396-8. PubMed ID: 15705639
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new antibiotic against respiratory tract infections. More power against pneumococci].
    MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
    Lee WK; Young BW
    J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
    [No Abstract]   [Full Text] [Related]  

  • 30. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia.
    Leesik H; Ani U; Juhani A; Altraja A
    Medicina (Kaunas); 2006; 42(5):384-94. PubMed ID: 16778466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of doxycycline in acute infections of the lower respiratory tract.
    Lyons HA; Thomas JS; Heurich AE; Shepherd DA; Wetmore SD
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):24-31. PubMed ID: 1210
    [No Abstract]   [Full Text] [Related]  

  • 32. Antimicrobial resistance of Streptococcus pneumoniae isolates in Athens, Greece.
    Kanavaki S; Mantadakis E; Karabela S; Anatoliotaki M; Makarona M; Moraitou H; Pefanis A; Samonis G
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):693-6. PubMed ID: 16261303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
    Chiou CC; Hseih KS
    Acta Paediatr Taiwan; 2003; 44(2):67-74. PubMed ID: 12845845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of beta-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice.
    Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 1999 Mar; 43(3):367-71. PubMed ID: 10223592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia.
    Bhavnani SM; Forrest A; Hammel JP; Drusano GL; Rubino CM; Ambrose PG
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):99-101. PubMed ID: 18583085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistant Streptococcus pneumoniae in the community.
    Riley D; MacCulloch D; Morris AJ
    N Z Med J; 1997 Mar; 110(1040):107-8. PubMed ID: 9137315
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacodynamics of doxycycline.
    Cunha BA; Domenico P; Cunha CB
    Clin Microbiol Infect; 2000 May; 6(5):270-3. PubMed ID: 11168126
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro and in vivo pharmacokinetic/pharmacodynamic activity of clofoctol.
    Scaglione F; Dugnani S; Lucini V; Pannacci M; Paraboni L
    J Chemother; 2012 Aug; 24(4):201-6. PubMed ID: 23040683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).
    Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):143-147. PubMed ID: 29157954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Austrian syndrome caused by highly penicillin-resistant Streptococcus pneumoniae.
    Muñoz P; Sainz J; Rodríguez-Creixéms M; Santos J; Alcalá L; Bouza E
    Clin Infect Dis; 1999 Dec; 29(6):1591-2. PubMed ID: 10585831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.